Intravitreal injections at the Massachusetts Eye and Ear Infirmary: Analysis of treatment indications and postinjection endophthalmitis rates

British Journal of Ophthalmology

Volumn 97, Issue 4, 2013, Pages 460-465

  Englander, Miriam ^a   Chen, Teresa C ^a   Paschalis, Eleftherios I ^a   Miller, Joan W ^a   Kim, Ivana K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CEFTAZIDIME; CYCLOPENTOLATE; MOXIFLOXACIN; PEGAPTANIB; PREDNISOLONE; PREDNISONE; PROXYMETACAINE; RANIBIZUMAB; STEROID; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHORIORETINITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CORNEA EDEMA; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; FEMALE; HUMAN; HYPOPYON; INCIDENCE; INTRAVITREAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROBABILITY; RETINA EDEMA; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT INDICATION; VISUAL ACUITY; VITRECTOMY;

ACADEMIC MEDICAL CENTERS; ACUTE DISEASE; AGED; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; APTAMERS, NUCLEOTIDE; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MASSACHUSETTS; POSTOPERATIVE COMPLICATIONS; RETINAL DISEASES; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84875221674     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302435     Document Type: Article

References (25)

1. Ramulu PY, Do DV, Corcoran KJ, et al. Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol 2010;128:1335-40.
2. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003;110:979-86.
3. Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.e5.
4. Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 2006;113:633.e1-4.
5. Pilli S, Kotsolis A, Spaide RF, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 2008;145:879-82.
6. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
7. Scott IU, Flynn HW. Reducing the risk of endophthalmitis following intravitreal injections. Retina 2007;27:10-2. (Pubitemid 46095824)
8. Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives. Clin Ophthalmol 2010;4:121-35.
9. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-6. (Pubitemid 37330020)
10. Young S, Morlet N, Besen G, et al. High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology 1998;105:1404-10. (Pubitemid 28509757)
11. Jager RD, Aiello LP, Patel SC, et al. Risks of intravitreous injection: a comprehensive review. Retina 2004;24:676-98. (Pubitemid 39391758)
12. Nelson ML, Tennant MTS, Sivalingam A, et al. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 2003;23:686-91. (Pubitemid 37315056)
13. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-82. (Pubitemid 37128405)
14. Singerman LJ, Masonson H, Patel M, et al. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol 2008;92:1606-11.
15. Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008;145:239-48.
16. Diago T, McCannel CA, Bakri SJ, et al. Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 2009;29:601-5.
17. Lima LH, Zweifel SA, Engelbert M, et al. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina 2009;29:1213-17.
18. Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-7. (Pubitemid 350167096)
19. Stein JD. Serious adverse events after cataract surgery. Curr Opin Ophthalmol 2012;23:219-25.
20. Aaberg TM, Flynn HW, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-10. (Pubitemid 28268323)
21. McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti- vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011;31:654-61.
22. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-75.
23. Bhavsar AR, Googe JM Jr, Stockdale CR. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol 2009;127:1581-3.
24. Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol 2011;129:1180-8.
25. Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol 2011;151:329-32.